Monika Raman, PSG College of Technology, Coimbatore By introducing new mutants, SARS-CoV-2 brings a new global threat with every new day. This current pandemic situation is a race between implementing vaccinations and controlling newly emerging infectious variants of coronavirus. To fight this situation, the Indian Institute of Science (IISc) in Bengaluru has successfully developed a […]
-Chitra Roy, University of Calcutta Covaxin, India’s indigenous COVID-19 vaccine, has been a subject of criticism due to its approval for restricted emergency use despite hot having published any phase 3 efficacy data. However, until recently, Bharat Biotech, the manufacturer of Covaxin claimed that its vaccine potentially generated safety data with the robust immune response […]
Chitra Roy, University of Calcutta An American biotechnology company ‘Moderna’, based in Cambridge, Massachusetts focuses on the discovery and development of drugs in addition to vaccine technologies. They exclusively use messenger RNA (mRNA) therapeutics and designs vaccines to create a completely new generation of transformative medicines. Against COVID-19, Moderna has developed its mRNA vaccine candidate […]
